Read r_7381.pdf text version

2011-2012

Board of directors

For millions of Americans, over-the-counter (OTC) medicines are a trusted and affordable way to get well, stay well, and feel well.

Each year, OTC medicines and dietary supplements provide Americans with affordable and convenient healthcare options. These medicines serve as a first line of defense against common ailments and deliver safe, effective, and affordable treatment for a wide variety of conditions such as pain, colds and allergies, infections, weight control, vitamin deficiencies, and nicotine addiction.

Yo u r H e a l t h A t H a n d . o r g

Contents

Contents

CHPA Executive Committee

1 Paul L. Sturman (Chair) Pfizer Consumer Healthcare Christopher D. DeWolf Lil' Drug Store Products, Inc. Timothy G. Hayes Bayer HealthCare LLC Patrick Lockwood-Taylor The Procter & Gamble Company Patrick M. Lonergan NUMARK Laboratories David J. Long, Esq. Reckitt Benckiser Inc. Colin I. Mackenzie GlaxoSmithKline James J. Mackey Merck Consumer Care Brian J. McNamara Novartis Consumer Health, Inc. James L. Medford Aaron Industries, Inc.

2

3 4

5

6

7

8

9

10

11 12 13

Patrick D. Mutchler Johnson & Johnson Jeffrey R. Needham Perrigo Company Adam D. Raczkowski W.F. Young, Inc.

28 29 30 31 32 33 34 35 36 37 38 39 40 41 42

Susan E. James GlaxoSmithKline Edward C. Kuehnle Catalina Marketing Corporation Matthew M. Mannelly Prestige Brands Holdings, Inc. Diane K. Manwaring Lansinoh Laboratories, Inc. Daren Mazzucca Midwest Living, Meredith Corporation Thomas M. Millikin The Procter & Gamble Company Dennis M. O'Donnell Matrixx Initiatives, Inc. Jeffrey R. Rowan Fleet Laboratories Paul Scoggins Johnson&Johnson·MerckConsumer Pharmaceuticals Co. Bill Seiden Taro Pharmaceuticals U.S.A., Inc. Randy M. Sloan Lornamead, Inc. Peter N. Stevens, Esq. GlaxoSmithKline Neill B. Walsdorf, Jr. Mission Pharmacal Company David J. Wendland Hamacher Resource Group Robert M. Wengel The Nielsen Company

CHPA Directors

17 Christopher B. Ascher B.F. Ascher & Company, Inc. J.P. Borneman, Ph.D. Hyland's, Inc. Christopher B. Combe Combe Incorporated Michael J. Donnantuono Blistex Inc. Gary R. Downing Insight Pharmaceuticals Corp. Phillip W. Dritsas Fleming Pharmaceuticals Scott R. Emerson DSE Healthcare Solutions, LLC Zan Guerry Chattem, Inc. Patrick Hennig Boehringer Ingelheim Pharmaceuticals, Inc. Jeffrey S. Himmel Himmel Pharmaceuticals Inc. Sheila Hopkins Colgate-Palmolive Company

18 19 20 21 22 23 24 25 26 27

43 44 45 46

Paul J. Weninger Perrigo Company Steven B. Woolf Humco Holding Group, Inc. Akiyoshi Yoshida, Ph.D. The Mentholatum Company Michael A. Zeher Nutrition 21, Inc.

CHPA Executive Committee

CHPA Executive Committee

CHPA Staff Officers

49 50 51 52 53 54 55 56 Scott M. Melville Roman G. Blazauskas Bill Head Barbara A. Kochanowski, Ph.D. Theodore L. Peterson Heinz Schneider, Dr. med. Emily Skor David C. Spangler, Esq.

57

CHPA Chairs

Paul L. Sturman

CHPA Chair President and General Manager Pfizer Consumer Healthcare Education: Born: Spouse: B.S. and M.B.A., Bucknell University May 19 Kelly

Sturman is president, Pfizer Consumer Healthcare (PCH), and is responsible for all aspects of the business unit's global operations, including the development and marketing of major household brands such as Advil®, Centrum®, Caltrate®, Chapstick®, and Robitussin®. PCH is among the largest over-the-counter (OTC) healthcare products companies in the world. In 2010, the business unit achieved global sales of approximately $2.8 billion while operating in over 65 countries. PCH's mission is to bring differentiated, science-based selfcare solutions to consumers, enhancing their health and well-being. Sturman transitioned to Pfizer from Wyeth Consumer Healthcare, which he joined in December 2008 as president, U.S. and Global Business Development, New Products. Sturman was previously part of Pfizer's Consumer Healthcare Business prior to its sale to Johnson & Johnson. While at J&J he served as president, North America, Consumer Healthcare, where he was responsible for overall business performance, financial results, strategy development, and execution across four major product categories and more than 30 brands including Listerine®, BandAid®, Stayfree®, Monistat®, Rogaine®, Neosporin®, and Visine®. His responsibilities also included Oral Care and Topical Health Global franchises and centers of excellence for Professional Sales and Marketing, and Market Research across the J&J U.S. Consumer Group. During his previous time at Pfizer, Sturman led U.S. Marketing and directed the turnaround of Pfizer's Canadian Consumer Healthcare business. He joined Warner-Lambert (which was acquired by Pfizer in 2000) as an assistant brand manager in 1984 and held positions of increasing responsibility in Marketing and Sales including director; national accounts; vice president U.S. Chewing Gum; and vice president, Global Category Management, for Halls® Cough Tablets.

CHPA Leadership:

·Chair,Boardof Directors, 2011·Chair-Elect,2010-2011 ·Chair,Personnel Committee, 2011·ExecutiveCommittee, 2009·ElectedtoBoardof Directors, 2009

1

Christopher D. DeWolf

CHPA Immediate Past Chair President & Chief Executive Officer Lil' Drug Store Products, Inc. Education: Born: Spouse: CHPA Leadership:

·Chair,Boardof Directors, 2009-2011 ·ImmediatePastChair, 2011·Chair,Personnel Committee, 2009-2011 ·Chair,Business Development Committee, 2008-2009 ·ViceChair,Business Development Committee, 2007-2008 ·ExecutiveCommittee, 2009·ElectedtoBoardof Directors, 2007

Timothy G. Hayes

CHPA Vice Chair President, Consumer Care North America; Head, Global Business Development and Licensing Bayer HealthCare LLC Education: Born: Spouse: B.A., Business & Marketing, Furman University September 7 Susan

B.A., Finance, University of Iowa M.B.A., J.L. Kellogg Graduate School of Management, Northwestern University December 11 Suzanne (Suzy)

DeWolf holds the position of president & chief executive officer and is the co-owner of Lil' Drug Store Products, Inc., a global consumer products company located in Cedar Rapids, Iowa. Prior to joining Lil' Drug Store Products, Inc., DeWolf held a number of leadership positions within the General Electric Company (GE) including corporate finance, operations, acquisition, and business development positions with GE Healthcare. DeWolf serves on the board of trustees of Junior Achievement of Eastern Iowa. While serving with Junior Achievement, he has held positions as Resource Generation Committee chair, vice chair, and chair of the board of directors. An active supporter of the University of Iowa's Henry B. Tippie College of Business, he has been a professor for undergraduate business courses. DeWolf is chair-elect of the board of directors of The Greater Cedar Rapids Community Foundation, a public charitable foundation holding more than 500 different funds, large and small, established by individuals, families, nonprofit agencies, and businesses to benefit Linn County, Iowa. DeWolf is an active member of the Young Presidents' Organization, a global networking and professional development society.

Hayes joined Bayer in 1992, bringing with him 12 years of experience in the consumer products business from The Quaker Oats Company. Since then, he has held positions of increasing responsibility in Bayer Consumer Care marketing, sales, and strategic business management, serving since 2000 as senior vice president, and head of Consumer Care's North American region. In July 2010, he took over responsibility for Bayer Consumer Care's Global Business Development and Licensing function. Hayes assumed his current position in May 2011, and is responsible for Bayer's over-the-counter drug and nutritionals businesses in the United States and Canada Hayes is former vice chairman of the board of the American Foundation for Pharmaceutical Excellence (AFPE). He currently serves on the advisory board of the Healthcare Business Women's Association (HBA).

CHPA Leadership:

·Chair,Boardof Directors, 2004-2006 ·ImmediatePastChair, 2006-2011 ·ViceChair,2001-2003, 2011·Chair-Elect,2003-2004 ·Chair,Associate Member Advisory Committee, 2004-2006 ·Chair,Personnel Committee, 2004-2006 ·Chair,Planning Committee, 2004-2006 ·Chair,Finance Committee, 2000-2003 ·ExecutiveCommittee, 2000·ElectedtoBoardof Directors, 2000

2

3

Patrick Lockwood-Taylor

CHPA Vice Chair Vice President, Personal Health Care, North America, and Brand Franchise Leader Digestive Wellness The Procter & Gamble Company Education: Born: Spouse: CHPA Leadership:

·ViceChair,2011 ·ExecutiveCommittee, 2011·ElectedtoBoardof Directors, 2011

Patrick M. Lonergan

CHPA Vice Chair Partner, President NUMARK Laboratories Education: Born: Spouse: B.S., Business, Northern Illinois University June 9 Gloria

First Class Joint Honors Degree, Economics & Management, Leeds University; Post Graduate Diploma, Marketing, Chartered Institute of Marketing, London January 4 Sarah

Lockwood-Taylor joined The Procter & Gamble Company as an account manager in Newcastle, UK, in 1991. He moved through the ranks serving as unit manager (London), district manager (Southern England), and sales & operations manager (West Africa) before moving to P&G headquarters in Cincinnati, Ohio, as a global project manager. He spent five years at headquarters before being named country manager in Malaysia. Over the next three years, he added the positions of general manager for Feminine and Baby Care and Personal Health to his resume, and was named general manager, ASEAN, for Australasia, India, Korea, and Japan Feminine Care and Asia Health Care in 2008. In 2009 Lockwood-Taylor was promoted to vice president, ASEAN (Australasia, India, Korea, and Japan Feminine Care and Asia Health Care), became vice president, NA Feminine Care and Tampax Brand Franchise Leader in 2010, and was named to his present position in 2011. He is involved in several local and international organizations, serving as vice president of AMCHAM in Malaysia and the Malaysian International Chamber of Commerce, and as chairman of Open Minds Charity. An avid runner, Lockwood-Taylor has participated in three Boston Marathons (2007, 2008, and 2009) as well as the SunTrust Richmond Marathon in 2009. He has participated in several triathlons, and enjoys restoring antique furniture.

Prior to co-founding NUMARK Laboratories, Lonergan was with Johnson & Johnson from 1959-1989, where he held various positions from sales representative to vice president & general manager. While at J&J, he was a member of the board of directors of Johnson & Johnson Products, Inc., and was chairman of the Health Care Division Management Committee. Lonergan is a member of numerous major consumer goods trade associations and has served as business chairman for the National Association of Chain Drug Stores and chairman of the National Wholesale Druggists' Association Industry Development Committee. He was also a member of the executive committee of the New Jersey Red Cross. Currently, Lonergan serves on the board of Prestige Brands Holdings, Inc., an NYSE-traded company, as well as the boards of several private OTC drug companies. In addition, he serves on the board of the St. Hubert's Animal Welfare Association in Madison, New Jersey.

CHPA Leadership:

·ViceChair,1999·Chair,Membership Committee, 2006·Chair,AnnualExecutive Conference Business Program Committee, 2003 ·Chair,PublicAffairs Committee, 1996-2002 ·Chair,Self-Medication Symposium Task Group, 1998-1999 ·ExecutiveCommittee, 1997·ElectedtoBoardof Directors, 1995

4

5

David J. Long, Esq.

Vice President, Regional Regulatory & Medical Affairs Reckitt Benckiser Inc. Education: Born: Spouse: CHPA Leadership:

·Chair,Government Affairs Committee, 1996-2000 ·Ex-officio member, Board of Directors, 1996-2000 ·ExecutiveCommittee, 2009·ElectedtoBoardof Directors, 2008

Colin I. Mackenzie

President, North America Consumer Healthcare GlaxoSmithKline Education: Born: Spouse: B.Sc., Applied Biological Sciences, Bristol Polytechnic, Bristol, UK February 14 Elizabeth

A.B., Government/History, Harvard University J.D., Georgetown University Law Center M.B.A., Fairleigh Dickinson University October 4 Melissa

Long began his career in 1974 in the New York office of Winthrop, Stimson, Putnam & Roberts, where he specialized in corporate litigation. He joined the Warner-Lambert organization in 1984 as associate counsel, corporate litigation, becoming counsel for the Parke-Davis Division in 1986. Long moved to the regulatory and government affairs side in 1988 when he was named vice president and associate general counsel. He spent six years as chief counsel, HealthCare Products, for Schering-Plough HealthCare Products, where his duties included negotiating and drafting supply, consulting, vendor, distributor, and agency agreements (among others); reviewing OTC labeling and advertising; antitrust and trade regulation; dispute resolution; and general counseling. Long joined Adams Respiratory Therapeutics as senior vice president, Regulatory Affairs, in mid-2006, where he reported directly to the chief operating officer, and assumed his present position following Adams' acquisition by Reckitt Benckiser in January 2008. Long has served as chair of the E-Commerce Subgroup of the FDA Regulatory Focus Group for the Pharmaceutical Research and Manufacturers Association, as well as of CHPA's DEA Issues Task Force. He is currently a member of the bars of New York and New Jersey.

Mackenzie was appointed to his present position in January of 2011. In this role, he heads the operations, sales, and marketing areas of GSK's Consumer Healthcare North America, including its wellrecognized brands such as alli®, Aquafresh®, Sensodyne®, and Tums®. Mackenzie began leading the U.S. Oral Care business in 2007, serving as vice president, Oral Care and Professional Marketing for GSK Consumer Healthcare. While there, he brought the professional and consumer Oral Care marketing teams together, leveraging a powerhouse brand portfolio with the consumer and dental communities. He also accelerated the U.S. Oral Care business's new sales growth rate, and acquired the leading dry mouth product, Biotene®, in 2008. In 1996, Mackenzie joined Smithkline Beecham in the United States as director of the Gastrointestinal Category Management Team, holding geographical responsibility for Southeast Asia/ China. From there, he moved to multiple leadership positions with responsibilities across the globe, including vice president, Strategic Advertising and Marketing Leadership; vice president, Aquafresh Future Team; and vice president and general manager, Central and Eastern Europe. Mackenzie began his career with Johnson & Johnson in the UK, where, over a period of 11 years, he held various leadership roles in both the UK and United States. Mackenzie is a former board member of the Personal Care Products Council.

CHPA Leadership:

·Chair,AnnualExecutive Conference Business Program Committee, 2012·ExecutiveCommittee, 2011·ElectedtoCHPABoard of Directors, 2011

6

7

James J. Mackey

CHPA Vice Chair Senior Vice President, US Region Head Merck Consumer Care Education: Born: Spouse: B.A., Marketing, St. Joseph's University August 12 Mary Ann

Brian J. McNamara

CHPA Vice Chair President, Region Head OTC Americas Novartis Consumer Health, Inc. Education: Born: Spouse: B.S., Electrical Engineering, Union College M.B.A., University of Cincinnati March 27 Kathy

CHPA Leadership:

·ViceChair,2005·Chair,AnnualExecutive Conference Business Program Committee, 2011·Chair,PublicAffairs Committee, 2004-2005 ·ExecutiveCommittee, 2003·ElectedtoBoardof Directors, 2003

In his capacity as senior vice president, Mackey is responsible for leading Merck's U.S. Consumer Care business. Mackey joined Schering-Plough in 1990 as vice president, Footcare Sales. Schering-Plough was acquired by Merck and Co. in 2009. He has held various sales and marketing positions of increasing responsibility in both Schering's Consumer and Pharmaceutical businesses. His consumer healthcare experience spans over two decades and includes managerial positions in the Whitehall Division of American Home Products Corporation (later Wyeth and now Pfizer Consumer Healthcare) and Sterling Drug Company (now Bayer HealthCare LLC). Mackey's affiliations include associate board member of the National Association of Chain Drug Stores, board member of the Personal Care Products Council (formerly The Cosmetics, Toiletry, and Fragrance Association), and board member of New Jersey D.A.R.E.

McNamara serves as the president and region head of the Americas Region for Novartis Consumer Health's Over-the-Counter Business Unit. In this role, he is responsible for all commercial operations for North America and Latin America. He was named to this role in August 2010, and is a member of the OTC Global Leadership Team. He joined Novartis OTC in 2004 as senior vice president and general manager of OTC North America. In that role he successfully led two years of record sales and profit growth as well as being instrumental in the acquisition of the consumer health products portfolio from Bristol-Myers Squibb, an acquisition that added Excedrin® to Novartis' portfolio. He also played a key role in Novartis gaining the rights to the Prevacid® prescription-to-OTC switch. In 2007, McNamara was appointed president and region head of Europe. In this role, he steadily grew the business while leading an organization of 1,500 people with responsibility for profit and loss across operations in 27 countries. He played a key role in driving the Voltaren franchise and was instrumental in licensing Pantoloc Control® from Nycomed, which led to the largest pan-European product launch for OTCs in several years. Prior to joining Novartis, McNamara gained extensive experience in consumer and brand marketing, product supply, and customer leadership during his tenure with The Procter & Gamble Company, where he began his career. His experience at P&G included manufacturing operations and brand management where he led a number of P&G's laundry businesses, including Tide®. McNamara is a former board member of the Economic Affairs Committee of the Association of the European Self-Medication Industry (AESGP) where he served as chairman of the Economic Affairs Committee.

CHPA Leadership:

·ViceChair,2006-2007, 2011·Chair,AnnualExecutive Conference Business Program Committee, 2007 ·ExecutiveCommittee, 2004-2007, 2010·ElectedtoBoardof Directors, 2004, 2010

8

9

James L. Medford

President, Chief Executive Officer, and Chairman of the Board Aaron Industries, Inc. Education: Born: Spouse: B.A., College of DuPage February 12 Denise

Patrick D. Mutchler

CHPA Vice Chair Company Group Chair, U.S. OTC, McNeil Nutritionals, Wellness & Prevention Johnson & Johnson Education: Born: Spouse: B.A., Journalism, University of Kentucky March 15 Ann Thompson

CHPA Leadership:

·ExecutiveCommittee, 2011·ElectedtoBoardof Directors, 2009

Medford has been president, chief executive officer, and chairman of the board of Aaron Industries, Inc., in Clinton, South Carolina, since 2000. Aaron Industries, Inc., is a leading manufacturer of private label/store brand OTC pharmaceuticals. Medford came to Aaron Industries, Inc., in 1998 from Charlotte, where he was president and chief operating officer of East Coast Marketing/Atlas Marketing. Medford is the father of two and a delegate of the National Republican Party Business Advisory Council for South Carolina, chairman of the Piedmont Technical College Board of Directors, and a member of both the Self Regional Healthcare Board of Trustees and Foundation Board of Directors. In addition, he serves on the board of directors for the Greenwood Partnership Alliance and the board of trustees at Presbyterian College, and is committee head for the college's School of Pharmacy. He is a member of the Teen Challenge Northern California Board of Directors, a pastpresident of the Charlotte Food Brokers, and a former member of the Georgia Pacific Broker and M&M Mars Broker advisory councils.

Mutchler began his career with the Johnson & Johnson Family of Companies in 1976 as a sales representative and advanced through sales and management positions of increasing responsibility. In 1993, he was named vice president of sales for the Personal Products Company and became its president in 1995. In 2001, he was named company group chairman with responsibility for the Asia Pacific Region, Emerging Markets, the Global Customer Council, and the Baby/Kids/Wound Global Franchise businesses. In 2006, he assumed a new role leading the Johnson & Johnson Global Market Organization, Global Supply Chain Organization, Global Customer Council, and Emerging Markets. In 2009, he was given responsibility for the Baby Global Business Unit, Baby Center, Global Customer Development, Office of Sustainability, Global Strategic Insights, and the new Digital Center of Excellence In his current role as the company group chairman of Johnson & Johnson, Mutchler oversees the U.S. OTC, McNeil Nutritionals,Wellness&Prevention,andtheJohnson&Johnson· Merck Consumer Pharmaceuticals Company. Additionally, he serves as a member of the Consumer & Personal Care Group Operating Committee. Currently Mutchler serves on the Corporate Board of the Philadelphia Museum of Art and the Johnson & Johnson Corporate Contributions Board, and is the executive sponsor of the Women's Leadership Initiative. He is also a past member of the Asia Society Business Council and Board of Directors of Abington Friends School.

CHPA Leadership:

·ViceChair,2011·ExecutiveCommittee, 2011·ElectedtoBoardof Directors, 2011

10

11

Jeffrey R. Needham

CHPA Vice Chair Executive Vice President and General Manager, Consumer Health Care Perrigo Company Education: Born: Spouse: B.A., Advertising, Michigan State University May 17 Erin

Adam D. Raczkowski

President and Chief Operating Officer W.F. Young, Inc. Education: Born: Spouse: B.S., Accounting, Boston College M.B.A., Finance, Northeastern University July 20 Toni

CHPA Leadership:

·ViceChair,2009·ExecutiveCommittee, 2009·ElectedtoBoardof Directors, 2009

Needham joined Perrigo in 1984 and has held numerous positions of increasing responsibility in marketing and business development. Prior to his current position, Needham was senior vice president of Perrigo's Commercial Business Development from 2005 to 2009. He was named vice president, Marketing, in 1993. In his present position, Needham has commercial responsibility for Perrigo's global consumer healthcare business including the development and implementation of long-term strategic direction. Needham came to Perrigo from Amway Corporation where he held positions in international marketing from 1980 to 1984.

Raczkowski began his career with GTE in its Financial Executive Development Program. Upon successful completion, he worked in the GTE Entertainment Products Group as the Philco corporate financial analyst. In 1981, he joined the Gillette Safety Razor Division and held many jobs of increasing responsibility within the financial and marketing areas. After working in the retail industry as the manager of financial planning for the Fayva Shoe Division of Morse Shoe, Inc. (1985), Raczkowski joined Allied Printing Company in 1986, where he was responsible for administrative and financial management. He joined W.F. Young in 1992 and has moved upward through the ranks in the areas of finance, operations, marketing, and sales. Raczkowski was named executive vice president, chief operating officer, chief financial officer, and general manager in 2002, and assumed his present position in 2008. Currently, he serves on the CHPA Audit, Finance, and Business Development Committees. Raczkowski is a Certified Management Accountant (CMA) and he is a member of the Institute of Management Accountants. He currently serves as treasurer of the East Longmeadow Educational Endowment Fund and is a member of the Springfield, Massachusetts, Homeless Employment and Training Committee.

CHPA Leadership:

·Chair,Finance Committee, 2009·Chair,Business Development Committee, 2004-2006, 2009-2010 ·Ex-officio member, Board of Directors, 2004-2006 ·ExecutiveCommittee, 2008·ElectedtoBoardof Directors, 2008

12

13

CHPA Directors

CHPA Directors

Christopher B. Ascher

Co-Owner/President B.F. Ascher & Company, Inc. Education: Born: Spouse: B.S.B.A., Marketing, Rockhurst University July 30 Cynthia

After receiving his degree in marketing from Rockhurst University, Ascher joined his family's business as medical service representative in East Texas, a position he held for five years. In July 1990, he was promoted to national account manager. In that position, Ascher started the company's national account department for chain drug distribution. In early 1997, he was promoted to director of sales and marketing, and to vice president, marketing & sales, in February 1998. Ascher was named executive vice president in July 2001 and executive vice president, Sales & Marketing, in 2006. He became co-owner/president in June of 2010. Ascher is a member of CHPA's Audit, Business Development, and Membership committees.

CHPA Leadership:

·ElectedtoBoardof Directors, 2001

17

J.P. Borneman, Ph.D.

Chairman & Chief Executive Officer Hyland's, Inc. Education: B.S. and M.S., Chemistry, St. Joseph's University M.B.A., St. Joseph's University Ph.D., Health Policy, University of Sciences, Philadelphia October 18 Anne Marie, Ed.D.

Christopher B. Combe

Chairman Combe Incorporated Education: Born: Spouse: B.A., Economics, Northwestern University July 4 Courtney

Born: Spouse: CHPA Leadership:

·Chair,PoliticalAction Committee, 2009·ElectedtoBoardof Directors, 2007

Borneman was Hyland's president for 10 years before being named to his current post in 2006. He served in a number of positions with the Standard Homeopathic Company, starting as director of marketing and moving through the ranks to achieve the title of chairman and chief executive officer. From 1983-1986, Borneman was vice president of Boiron-Borneman, Inc. He began his career as vice president of John A. Borneman and Sons, Inc. Borneman's professional affiliations include the American Pharmacists Association, American Chemical Society, Sigma Xi, and the American Public Health Association. He has served as a board member for the International Foundation for Homeopathy. In 2008, he became president of the Homeopathic Pharmacopeia Convention of the United States, and has chaired that body's Council on Pharmacy. Borneman is active with the National Association of Chain Drug Stores, the National Center for Homeopathy, the American Homeopathic Pharmaceutical Association, and the American Association of Homeopathic Pharmacists, and was awarded the American Chemical Society's medal for service. He is a trustee of the Southwest College of Naturopathic Medicine, an adjunct associate professor of public health at the University of the Sciences in Philadelphia, and an advisory board member of St. Joseph's University's College of Arts and Sciences. Borneman has authored numerous papers and is a guest lecturer at many seminars, pharmacy association meetings, and secondary education institutions and universities.

Combe serves as chairman of Combe Incorporated, a 62-year old, privately held global manufacturer and marketer of health and beauty care products, headquartered in White Plains, New York. Combe markets well-known brands such as Vagisil®, Just For Men®, Aqua Velva®, Lectric Shave®, Brylcreem®, and Sea-Bond®. Combe spent five years in sales and marketing with American Hospital Supply Corp. (now Baxter International) before joining Combe Incorporated as manager of international marketing services. He attained positions of increasing responsibility, rising to vice president of international and vice president of marketing, and assumed the position of president and chairman in early 2000. During his 10 years developing Combe's international affairs, he launched its business in Japan, Australia, and New Zealand, and lived in Europe for four years managing the company's business throughout that area. He is chairman of the World Self-Medication Industry (WSMI) as well as a member of the board of directors of the Personal Care Products Council (PCPC). Combe is very active in civic and charitable organizations as a member of the Boy Scout Board of Directors for Greenwich, Connecticut, as well as the Boy Scout Advisory Council of Westchester, New York. He is involved with the American Heart Association, serves as chairman of the Men's Ministry at his church, and is a member of the board of trustees at Northwestern University.

CHPA Leadership:

·ElectedtoBoardof Directors, 2011

18

19

Michael J. Donnantuono

President & Chief Operating Officer Blistex Inc. Education: Born: Spouse: B.A., History, Harvard University M.B.A., Marketing, Columbia University July 10 Jane

Gary R. Downing

Chief Executive Officer Insight Pharmaceuticals Corp. Education: Born: Spouse: B.S., Marketing, Southeast Missouri State University June 25 Jennifer

CHPA Leadership:

·ElectedtoBoardof Directors, 2007

Donnantuono joined Blistex in 1990, and moved through the positions of category manager and vice president of marketing (reporting to former CHPA Chair Richard Green) before assuming his current responsibilities in 2003. Before joining Blistex, Donnantuono worked in brand management at The Procter & Gamble Company for six years in categories ranging from coffee to hair care. Prior to that experience, he worked before and during his graduate business school studies in a number of shorter-term finance and marketing jobs and paid internships, including one at Nabisco Brands. Donnantuono currently serves on the Community Advisory Council of Loaves & Fishes (a food bank and essential services provider for the needy), is a member of the Economic Development Council of the Oak Brook Chamber of Commerce, and provides help on an ad hoc basis at Hesed House (a homeless resource center). All are located in the suburban Chicago region.

Downing spent 12 years with Richardson-Vicks in various sales and marketing positions before joining Oral-B Laboratories in 1984 as vice president, sales, which included professional markets as well as the operations functions. In 1989, he joined Rhone-Poulenc Rorer as vice president of sales of the U.S. OTC business; became general manager in 1990; and he assumed additional responsibilities for all of North America, including Canada, Mexico, and Puerto Rico, in 1991. He became president of Medtech Laboratories, Inc., in April 1995 and chief executive officer in March 1998. Downing was named chief executive officer with Lansinoh Laboratories, Inc., in 2002, and assumed his present position with Insight Pharmaceuticals in March of 2010.

CHPA Leadership:

·Chair,Auditing Committee, 2000-2001 ·Chair,Business Development Committee, 2001 ·ElectedtoBoardof Directors, 1991, 1995, 2003, 2010

20

21

Phillip W. Dritsas

President Fleming Pharmaceuticals Education: Born: B.A., University of Minnesota M.A., Management, Health & Human Services, St. Mary's University August 1

Scott R. Emerson

Partner DSE Healthcare Solutions, LLC Education: Born: Spouse: B.A., Accounting and Business Management, Southwest Texas State University September 19 Yvonne

CHPA Leadership:

·Chair,Business Development Committee, 2010·ElectedtoBoardof Directors, 2009

Dritsas brings more than 24 years of pharmaceutical industry experience to his position as president of Fleming Pharmaceuticals, where his main responsibility is to lead new corporate and product strategy, prepare for pending approval of new products in clinical development with the U.S. Food and Drug Administration, and expand the company's marketing and selling capabilities. During his more than two decades in the pharmaceutical industry, Dritsas has launched major brands and generic entries, prescription as well as OTC, and helped grow his previous employer into a notable pharmaceutical company. Since coming to Fleming in 2006, Dritsas has led the expansion of the Ocean® Nasal Saline product line and market share through new product introduction and focused market and selling efforts to healthcare professionals. Dritsas carries on company founder Tom Fleming's mantra of challenging convention with honesty and integrity, using a hands-on approach which often has him rolling up his sleeves and working beside all levels of personnel. Before joining Fleming Pharmaceuticals, Dritsas served as vice president of sales and marketing for Upsher Smith Laboratories Inc. of Maple Grove, Minnesota.

Emerson is the founder and president of The Emerson Group and Emerson Healthcare. The Emerson Group is an industry-leading provider of consulting and sales execution services. Emerson Healthcare, an Emerson Group division, provides centralized invoicing, order processing, warehousing, and shipping. Emerson is also a founding partner in DSE Healthcare Solutions, a marketer of innovative, one-of-a-kind niche brands. Emerson has 30 years of experience with companies including Johnson & Johnson, Unilever, and Novartis Consumer Health. He has held senior management positions in Fortune 500 companies within brand management, new business development, sales operations, and field sales. The Emerson Group, with its field sales infrastructure of 10 regional offices, holds equity positions with small- and medium-size brands. It also operates internationally, providing partners in the European and Asian Pacific regions with the expertise and infrastructure necessary to successfully penetrate the U.S. market. The company provides a range of services including its core competency: field sales management. DSE Healthcare Solutions, Inc., founded in 2005, is a rapidly growing consumer goods marketer of innovative niche brands. Emerson's role in founding the company is providing advice and expertise on trade issues and strategies.

CHPA Leadership:

·ElectedtoBoardof Directors, 2006

22

23

Zan Guerry

Chief Executive Officer Chattem, Inc. Education: Born: Spouse: CHPA Leadership:

·ElectedtoBoardof Directors, 1994

Patrick Hennig

Vice President, Marketing and Sales Boehringer Ingelheim Pharmaceuticals, Inc. Education: Born: Spouse: Diplomkaufmann (M.B.A. equivalent), University of Kiel, Germany December 11 Bettina

Baylor School, Rice University M.B.A., University of Pennsylvania Wharton School of Business February 7 Julie

Guerry began his career as a financial analyst at Coca-Cola U.S.A. from 1973-1974 and at Texas Commerce BancShares from 19751976. Joining Chattem, Inc., in 1978, he became its chief financial officer in 1980 and executive vice president in 1983. He assumed his present position in 1990. Guerry is chairman of the United Way of Chattanooga and served as the campaign chair for 1996, is chairman of the board of the Baylor School in Chattanooga, serves as a board director of the SunTrust Bank-Chattanooga, and is a board trustee of the University of Chattanooga Foundation and chairman of its endowment committee. In 1997 Guerry had the honor of being selected as the Chattanooga Area Manager of the Year. A four-year All-American at Rice University, where he served as captain of the tennis team, Guerry has won many championship tennis titles. In his pro tennis career, he was ranked in the men's top 20 five times and was a five-time winner of Southern Men's Championships.

Hennig assumed his present position with Boehringer on April 1, 2005. Prior to this assignment, he served as the head of marketing and sales for Consumer Health Care at Boehringer in Venezuela (2001-2005), where he built the CHC business unit. Before moving to Venezuela, Hennig spent four years at Boehringer's headquarters in Germany, first as an international product manager and then as international marketing manager, responsible for the worldwide brands within the CHC cough and cold and gastrointestinal categories. Hennig began his career at Boehringer in 1997, coming from a background in the consumer packaged goods industry at companies such as United Distillers.

CHPA Leadership:

·ElectedtoBoardof Directors, 2006

24

25

Jeffrey S. Himmel

Chairman & Chief Executive Officer Himmel Pharmaceuticals Inc. Education: Born: Spouse: CHPA Leadership:

·Chair,Auditing Committee, 2001·ElectedtoBoardof Directors, 1994

Sheila Hopkins

Vice President & General Manager, Professional Oral Care Colgate-Palmolive Company Education: Born: B.A., History, Wellesley College August 23

B.S., Economics, University of Pennsylvania Wharton School of Business M.S., Taxation, Bentley College December 25 Patricia

Himmel is chairman and chief executive officer of Himmel Pharmaceuticals Inc. From 1992-2007, he was chairman and chief executive officer of Himmel Nutrition, which marketed Ovaltine® under license from Novartis Nutrition up until the sale of the brand to Nestle. Himmel marketed Gold Bond® Medicated Powder until the sale of that brand to Chattem, Inc., in 1996. He was formerly vice chairman and executive vice president of Jeffrey Martin, Inc., a marketer of over-the-counter pharmaceuticals, until its sale in 1986. He then joined the investment bank Rothschild Inc., where he became a managing director restructuring troubled companies. Prior to joining Jeffrey Martin, Himmel practiced as a certified public accountant with Arthur Young & Company and Laventhol & Horwath. Himmel was a member of the Undergraduate Executive Board of the Wharton School of the University of Pennsylvania (19992010) and is a trustee of The Himmel Foundation. In addition, he is a member of the American Institute of Certified Public Accountants (AICPA) and the New York State Society of Certified Public Accountants.

Hopkins is currently vice president & general manager, Colgate Professional Oral Care. This subsidiary manages Colgate-Palmolive's sales, profits, and image in the dental profession. A key role of the subsidiary is to drive professional endorsements of Colgate's oral care products. Previously, she was vice president, global business development, and had responsibility for strategic planning and business development for Colgate's Global Skin Cleansing and Hair Care businesses. Hopkins joined Colgate in 1997 as vice president, general manager U.S., Personal Care. Before joining Colgate, Hopkins was vice president of U.S. marketing for Tambrands. She also held sales and marketing positions at Shulton and Revlon Healthcare. Hopkins started her career at The Procter & Gamble Company. Hopkins is a member of the board of directors of Warnaco Inc., and serves on the boards of Volunteers of America of Greater New York and Pathways to College (a nonprofit organization committed to increasing minority enrollment in select four-year colleges). She has been recognized by Ad Age magazine as one of the Top 100 Women in Advertising, by the Harlem YMCA as a Black Achiever, and by the Girl Scouts of New York as an Extraordinary Woman.

CHPA Leadership:

·ElectedtoBoardof Directors, 2008

26

27

Susan E. James

Vice President, Worldwide Regulatory Affairs, Compliance and Quality GlaxoSmithKline Education: Born: Spouse: B.A., Chemistry/Biochemistry, York University, UK April 4 Ken

Edward C. Kuehnle

President, Catalina Marketing Services Catalina Marketing Corporation Education: Born: Spouse: B.S., Management/Marketing, St. Joseph's University September 29 Linda

CHPA Leadership:

·Chair,Regulatoryand Scientific Committee, 2009·Ex-officio member, Board of Directors, 2009-

James strategically plans, directs, and manages the global regulatory, R&D quality, and compliance activities for GSK Consumer Healthcare division's broad product portfolio, which includes OTC medicines, devices, supplements, and oral healthcare. James was recruited by Beecham Products (UK) as a laboratory scientist researching and developing OTC medicines in 1979. After gaining 12 years' experience, she fulfilled her ambition to move into regulatory affairs. In 1993 James transferred to the Parsippany, New Jersey, facility to gain direct experience in U.S. regulatory affairs. In 2000 she was appointed head of worldwide regulatory affairs and, in 2001, was promoted to vice president with additional responsibility for R&D regulatory compliance and subsequently R&D quality. In addition to CHPA activities, James has been an active member of the Regulatory Affairs Professional Society (RAPS) since 1993, serving on its board of directors since 2006. She is RAPS' president/chair for the 2010 ­ 2011 term. She also has been a member of The Organization for Professionals in Regulatory Affairs (TOPRA) since 1991.

As president of Catalina Marketing Services, a division of Catalina Marketing Corporation, Kuehnle has general management responsibility for generating domestic retailer and manufacturer support of new products, channels, and innovations in Catalina Marketing's core business. He is also charged with strategically aligning the 28-year-old consumer centric marketing company with emerging business trends, as well as further developing it as an industry thought leader. Since joining the company in 2005, Kuehnle has led Catalina Marketing Services into new channels, including the installation of the Catalina Marketing Network® in its first drug chain, mass merchandiser chain, and subsequently other key retailer chains, to improve the channel and ACV offering in order to reach several million shoppers everyday. He also played an integral role in transforming the company's core black and white communications to full-color, full-graphics prints. The latest direction is expanding Catalina's presence with the consumer in digital and mobile to complement the in-store network. Throughout all these initiatives, Kuehnle and the CMS Leadership Team have been successful in gaining continued and increased support from Catalina's retail and manufacturer partners by aligning with the industry's key issues. Kuehnle brings over 30 years of consumer packaged goods and pharmaceutical industry experience to Catalina. Prior to joining Catalina, Kuehnle held the position of group president, Information Resources, Inc., North America, where he spent six years. Prior to IRI, Kuehnle held executive leadership positions with Pharmacia, Bristol Myers Squibb, Wyeth Corporation, and Coopers & Lybrand. Kuehnle participates in several industry associations such as SIFE, GMA, FMI, NEW, NACDS, and GMDC. He also devotes time in the St. Petersburg community as a member of the board of trustees for All Children's Hospital. He also supports other charitable causes in Philadelphia and Chicago.

CHPA Leadership:

·ElectedtoBoardof Directors, 2002, 2007, 2010

28

29

Matthew M. Mannelly

Chief Executive Officer Prestige Brands Holdings, Inc. Education: Born: Spouse: B.S., Boston College M.B.A., University of North Carolina ­ Chapel Hill October 22 Kathy

Diane K. Manwaring

President, North America Lansinoh Laboratories, Inc. Education: Born: Spouse: B.S., Marketing, La Salle University April 12 Ed

CHPA Leadership:

·ElectedtoBoardof Directors, 2009

Mannelly has been chief executive officer and a member of the board of directors of Prestige Brands Holdings, Inc., as of September 3, 2009. He is an accomplished executive with extensive experience in consumer products, packaged goods, sports and fitness, and apparel. Prior to joining Prestige Brands, he was with Cannondale Bicycle Corporation for five years where he was chief executive officer. Mannelly's background also includes marketing, management, and retail development for well-known brand names such as Nike®, Gatorade®, Quaker Oats®, and the U.S. Olympic Committee. In 2008, Mannelly was named Distinguished Marketer of the Year by the Academy of Marketing Science and was a finalist in the 2007 Ernst & Young Entrepreneur of the Year competition for the New York metropolitan region.

Manwaring was appointed to her current position as president of Lansinoh Laboratories, North America, after working with the organization as a key business consultant for over five years. As president she is responsible for all corporate marketing, sales, operations, and new product development in the United States and Canada. Prior to joining Lansinoh, Manwaring was founder and president of DKM, Inc., a consultancy providing a wide range of brand and business services including strategic thinking, brand management, and acquisition evaluation for small- to mid-sized consumer products companies. Manwaring also served as senior vice president, Marketing, for Medtech, Inc., managing the U.S. marketing activities for all Medtech brands as well as sales and marketing for Canada. Prior to this, Manwaring spent nearly 30 years in sales, marketing, and new product development while working with SmithKline Consumer Products, a division of SmithKline Beecham, now GlaxoSmithKline; Rhone-Poulenc Rorer Consumer Products, a division of RhonePoulenc Rorer, now Sanofi-Aventis; and the Biologics Division of Centeon, now CSL Behring. Manwaring also serves on the board of the Biotechnology Foundation.

CHPA Leadership:

·ElectedtoBoardof Directors, 2010

30

31

Daren Mazzucca

Publisher Midwest Living, Meredith Corporation Education: Born: Spouse: B.S., Business Economics, Minor in Business Communications, Oneonta College June 30 Stephanie

Thomas M. Millikin

Associate Director, Worldwide External Relations, Personal Health Care The Procter & Gamble Company Education: Born: B.A., Communications/Broadcast Journalism, Xavier University M.B.A., Business, Indiana Wesleyan University January 5

CHPA Leadership:

·Chair,AnnualExecutive Conference General Activities Committee, 1999 ·ElectedtoBoardof Directors, 2011

Mazzucca is the publisher of Midwest Living, a Meredith Corporation publication. Prior to joining Meredith, he served as the associate publisher at Hearst Corporation's Good Housekeeping magazine. Mazzucca's advertising management background spans multiple magazine titles. He was associate publisher at Country Living magazine for five years, and prior to that held the title of vice president/advertising director for Parade magazine. He also spent five years as publisher of New Choices magazine. His career includes senior advertising and sales positions with Woman's Day magazine, Better Homes and Gardens, and Meredith's Special Interest Media publications. Mazzucca has been an active participant in CHPA activities since 1997, and served as the Annual Executive Conference General Activities Committee Chair in 1999. He is extremely familyand community-oriented, coaching youth soccer and serving as an active member in his parish's St. Vincent De Paul Society.

Millikin's prior business background is in the area of radio and television, as both a news anchor and reporter from 1987-1994. He became a pharmaceutical sales representative (1994-1997) for Ciba-Geigy, leaving to join the public affairs team at The Procter & Gamble Company, where he served until 2001. He left P&G to work in the public relations and communications department of Johnson & Johnson's Medical Device department (Ethicon EndoSurgery) and returned to P&G in 2004 when he took the position he currently holds in external relations. In addition to his other duties, Millikin serves on the P&G Political Action Committee. Millikin is heavily involved in coaching summer baseball travel teams for Cincinnati youth.

CHPA Leadership:

·Chair,PublicAffairs Committee, 2011·Ex-officio member, Board of Directors, 2011-

32

33

Dennis M. O'Donnell

President & Chief Executive Officer Matrixx Initiatives, Inc. Education: Born: Spouse: CHPA Leadership:

·ElectedtoBoardof Directors, 2011

Jeffery R. Rowan

President and Chief Executive Officer Fleet Laboratories Education: Born: Spouse: B.A., Chemistry, University of Wisconsin ­ Superior M.S.I.A., Purdue University ­ Krannert School of Management June 23 Karan CHPA Leadership:

·ElectedtoBoardof Directors, 2009

B.S., Pharmacy, St. John's University M.B.A., Marketing and Finance, New York University Leonard N. Stern School of Business October 28 Renee

O'Donnell is the recently named president and chief executive officer of Matrixx Initiatives, the makers of Zicam® products. Previously, he was president of NextWave Pharmaceuticals, a venture capital funded specialty pharmaceutical company focused on CNS products utilizing proprietary drug delivery technology. Before joining NextWave, O'Donnell was president of New York Health Care, a home healthcare services company which he restored to profitability, and chief executive officer of BioBalance Corporation, its wholly owned biotech subsidiary developing proprietary treatments for gastrointestinal disorders. Prior to BioBalance, he spent 18 years at Wyeth Consumer Healthcare in a number of marketing and general management positions. O'Donnell began his career as a professional sales representative with Bristol-Myers.

Rowan is the president and chief executive officer of Fleet Laboratories, a global manufacturer of personal care and healthcare products since 1869. He previously was the company's chief operating officer (COO). A 12-year company veteran, Rowan held several positions of increasing responsibility at Fleet, where he led the company's expansion into markets around the world. Before becoming COO in August 2007, he was responsible for overseeing global marketing and the company's international operations. Rowan's career included a variety of U.S. and international brand marketing positions with General Mills, Bayer Corporation, and other companies before joining Fleet in 1998.

34

35

Paul Scoggins

General Manager Johnson & Johnson · Merck Consumer Pharmaceuticals Co. Education: Born: Spouse: B.A., Economics, University of California, Davis M.B.A., Columbia University March 8 Andrew

Bill Seiden

Senior Vice President, U.S. Sales & Marketing Taro Pharmaceuticals U.S.A., Inc. Education: B.S., Industrial Engineering and Operations Research, Cornell University M.B.A., Marketing, St.John's University

CHPA Leadership:

·ElectedtoBoardof Directors, 2011

InhiscurrentpositionasgeneralmanagerofJohnson&Johnson· Merck Consumer Pharmaceuticals Co., Scoggins is responsible for the Pepcid®, Mylanta®, and Mylicon® digestive health businesses in the United States. Scoggins has been with Johnson & Johnson for six years. Prior to his current position, he was the worldwide vice president for J & J's Sanitary Protection Franchise with responsibility for the global Stayfree®, Carefree®, and o.b.® businesses. Before joining Johnson & Johnson, Scoggins lead the Clairol Hair Color business for The Procter & Gamble Company in North America. Scoggins started his career at Bristol-Myers Squibb where he held a number of marketing positions in the beauty and personal care categories in both the U.S. and Europe.

Taro Pharmaceuticals U.S.A., Inc., is the U.S. affiliate of Taro Pharmaceutical Industries Ltd. In his present position, Seiden oversees sales and marketing for Taro U.S.A. which represents approximately 90 percent of Taro's total annual sales. Taro's pharmaceutical products are used primarily in dermatology, pediatrics, cardiology, and neurology. Additionally, Taro is a contract manufacturer for several CHPA Active member companies. Seiden joined Taro in 1998 and has been instrumental in Taro's dramatic growth. His background as a pharmaceutical executive includes more than 26 years of experience at American Home Products Corporation (later Wyeth and now Pfizer Consumer Healthcare), Colgate-Palmolive Company, Lederle Laboratories, and Revlon. He has played central roles in managing and marketing such global brands as Advil, Anacin, Bayer, Colgate, Revlon, and other household names. In the past, Seiden served on CHPA's Marketing Committee.

CHPA Leadership:

·ElectedtoBoardof Directors, 2004

36

37

Randy M. Sloan

President and Chief Executive Officer Lornamead, Inc. Education: Born: Spouse: B.S., University of Pennsylvania M.B.A., University of Chicago January 20 Lisa

Peter N. Stevens, Esq.

Assistant General Counsel, Consumer Healthcare GlaxoSmithKline Education: Born: Spouse: B.A., Columbia College J.D., Columbia Law School February 21 Mary

CHPA Leadership:

·Chair,Business Development Committee, 2006-2008 ·Ex-officio member, Board of Directors, 2006-2008 ·ElectedtoBoardof Directors, 2008, 2009

Sloan was named to his current position in September of 2008, following the sale of Del Pharmaceuticals' OTC products. He began his career in marketing with Colgate-Palmolive in 1980. In 1984, he joined Ciba-Geigy to help start its Self-Medication unit. During his 12 years with Ciba, Sloan held a number of positions of increasing responsibility, including executive director of marketing, and vice president of marketing and business development. Prior to joining Del, Sloan spent two years as group vice president at PolyMedica Healthcare Inc., with operating responsibility for the consumer healthcare group. In 1998, he joined Del Pharmaceuticals as senior vice president of marketing, rising to the position of executive vice president, general manager in 2005, where he was responsible for overall management of the U.S. OTC business. Sloan is actively involved in University of Pennsylvania alumni activities as well as in a variety of local community organizations.

Stevens is the chief attorney for the GlaxoSmithKline Worldwide Consumer Healthcare R&D group. He also has legal responsibility for several OTC brand and switch teams, and oversees advertising litigation. Prior to joining GSK in 2001, Stevens had a 20-year tenure with Bristol-Myers Squibb. For 10 of those years he was vice president and general counsel for the Bristol-Myers Products Division and served as a member of the management team. His remaining time at the company was spent as a litigator defending the company in product liability and employment law matters. Stevens began his career as an assistant district attorney in the Manhattan District Attorney's Office in New York City.

CHPA Leadership:

·Chair,Government Affairs Committee, 2007·Ex-officio member, Board of Directors, 2007-

38

39

Neill B. Walsdorf, Jr.

President Mission Pharmacal Company Education: Born: Spouse: B.S., Advertising, The University of Texas at Austin November 14 Deena

David J. Wendland

Vice President Hamacher Resource Group Education: Born: B.S, Marketing and Communications, University of Wisconsin ­ Whitewater September 21

CHPA Leadership:

·ElectedtoBoardof Directors, 2002

Walsdorf joined the family business in 1978 while still a student, and literally learned the business from the assembly line floor on up. He was a physician sales representative (1982-1984), key accounts Midwest regional manager (1984-1986), and vice president of sales and marketing before assuming his present position in 1998. He is the third generation Walsdorf to run Mission Pharmacal. In addition to his corporate responsibilities, Walsdorf serves on the corporate advisory board of the National Osteoporosis Foundation, the advisory board of the University of Texas College of Communication, and is a member of the Young Presidents' Organization. He also previously served on the board of the Texas Pharmaceutical Foundation, the advisory board of the University of Texas Exes, and the International Densitometry Foundation. Walsdorf was a 2001 nominee for the prestigious Outstanding Young Texas Ex Award, which recognizes significant career achievements and service to The University of Texas, bestowed by the alumni society (the Texas Exes).

Wendland is vice president and part owner of Hamacher Resource Group (HRG), a retail healthcare consultancy located near Milwaukee, Wisconsin. He directs the business development, account management, product innovation, and marketing communications activities for the company and has been instrumental in positioning HRG among the industry's foremost thought leaders. A veteran of the industry, Wendland joined HRG in 1992 after gaining 11 years of experience in various sales and marketing roles, including managing his own San Diego-based advertising and marketing communications company. He is a regular columnist for Healthcare Distributor magazine, and a frequent BrainTrust Panelist on RetailWire. Wendland has diverse experience as an industry speaker, including presentations before the OTC National Conference, Drug Store News Diabetes Roundtable, ECRM Disease State Management event, and numerous other association and healthcare distributor-sponsored conferences. Wendland serves in a leadership role as part of the planning team for CHPA's Business Development Committee and related CHPA activities, and is an active member and participant for industry associations such as NACDS, NCPA, GMDC, and HDMA. A native of Wisconsin, Wendland is very active in the community and has served on the advisory boards of two Milwaukee-based non-profit organizations: The Salvation Army and Wisconsin Community Services.

CHPA Leadership:

·ElectedtoBoardof Directors, 2011

40

41

Robert M. Wengel

Senior Vice President, Professional Services The Nielsen Company Education: Born: Spouse: B.S., Marketing, University of Maryland, College Park November 6 Gina

Paul J. Weninger

Vice President, Consumer Healthcare Global Quality Operations Perrigo Company Education: Born: Spouse: B.S., Chemical Engineering, University of Wisconsin M.B.A., National University February 11 Kami

CHPA Leadership:

·ElectedtoBoardof Directors, 2010

Wengel has over 25 years of industry experience within leading CPG companies and as an analytic consultant to the industry. He is a senior leader in the Nielsen Professional Services Analytics team. He joined Nielsen in 2007, and works closely with leading health and consumer products companies, as well as being the lead sponsor of Nielsen's OTC/Health Analytic Community. Wengel started his career at The Procter & Gamble Company, where he held roles in Health & Personal Care sales management. He continued his career at Tambrands, where he held a variety of sales and marketing leadership assignments. From there, he went on to serve as national sales manager at Benckiser Consumer Products. In 1999, Wengel joined Information Resources, Inc., (now SymphonyIRI) as senior vice president of strategic solutions, where he progressed to lead the Analytic Insights Group and then served as executive vice president, Client Service. From IRI, Wengel ventured into new territory, as senior vice president, Sales and Operations, at Waterworks, a leading luxury design retailer. In 2006, he returned to his passion of market research and analytic consulting, joining TNS Custom Research, as executive vice president, Client Service.

Weninger joined Perrigo in 2001, and is currently the vice president of consumer healthcare quality operations for the company. Prior to assuming this role in 2008, he was vice president of Michigan manufacturing and packaging operations for Perrigo. Before joining Perrigo, Weninger worked in various supply chain and manufacturing roles for Kelco, a global manufacturer of hydrocolloids for the pharmaceutical and food industries. During this time, Kelco was owned by Merck, Monsanto, Pharmacia, and Huber. Weninger started his career with Pfizer Consumer Healthcare in Groton, Connecticut, as production engineer on bulk API. Overall, he has more than 21 years of operational, supply chain, and quality experience in a combination of API, excipient, and finished dosage form production.

CHPA Leadership:

·Chair,Manufacturing Controls Committee, 2010·Ex-officio member, Board of Directors, 2010-

42

43

Steven B. Woolf

Executive Vice President & Chief Financial Officer Humco Holding Group, Inc. Education: Born: Spouse: CHPA Leadership:

·ElectedtoBoardof Directors, 2011

Akiyoshi Yoshida, Ph.D.

President and Chief Executive Officer The Mentholatum Company Education: Born: Spouse: Ph.D., Pharmacy, Gifu Pharmaceutical University, Japan February 19 Michiko

B.S.B.A., Economics, University of Missouri M.B.A., Marketing, Bradley University CPA Certificate, State of Texas October 8 Paula

Woolf joined Humco Holding Group, Inc., as its chief financial officer in 2000 and was named to the board of directors in 2001. Among other duties, he currently leads the company's contract sales initiatives, asset utilization, and general financial operations. During his career, Woolf has contributed to the success of a number of high profile consumer products companies including Frito-Lay; Famous Amos Chocolate Chip Cookies; President International, Inc; Keebler Foods; and Caterpillar Tractor Company in the capital goods arena. Prior to joining Humco he orchestrated the sale of President International, Inc., (the leading supplier of Girl Scout Cookies) to Keebler Foods. Woolf served for over 10 years as senior vice president/chief financial officer of President International, Inc., with responsibility for business operations within the United States and China. Woolf's background also includes owning a pasta manufacturing/distribution company as well as marketing, management, and numerous M&A transactions within the consumer products space. In addition to holding a board seat at Humco, he serves on the board at one of the largest privately owned baking companies in the United States.

Yoshida joined Rohto, Mentholatum's parent company, after receiving his pharmacy doctorate from Gifu Pharmaceutical University. He has moved into positions of increasing responsibility, including general manager, where he was responsible for Rohto's Mentholatum business in Japan. Yoshida was appointed to Rohto's board of directors in 1992, and established and became managing director of Rohto's International Division. In 1998, Yoshida was named chairman of Rohto-Mentholatum Research Laboratories in Philadelphia, a company specifically formed to support Mentholatum's new product efforts. He was appointed to his present position in November 1999. In addition, he serves on the boards of directors of several other Rohto subsidiary companies.

CHPA Leadership:

·ElectedtoBoardof Directors, 2000

44

45

Michael A. Zeher

Staff Officers

President & Chief Executive Officer Nutrition 21, Inc. Education: Born: Spouse: B.S., Business Administration, Old Dominion University November 10 Linda

CHPA Staff Officers

CHPA Leadership:

·ElectedtoBoardof Directors, 2003, 2007, 2009

Zeher was named to his current position in summer 2008. Before coming to Nutrition 21, he held the position of president and chief executive officer at Nutritional Laboratories International, Inc., (NLI) prior to the sale of the company, where he was responsible for leading and executing the company's global strategies including quality assurance processes aligned with drug good manufacturing practices and new product development. Prior to joining NLI, Zeher was president and chief executive officer of Pharmaceutical Formulations, Inc., a manufacturer of over 100 different types of solid-dose OTC pharmaceutical products. Zeher has extensive global consumer packaged goods experience, having served for seven years as president and chief executive officer of Lander Company, Inc., a privately held personal care products company. His business responsibilities included involvement in the U.S., European, Latin American, and Asian markets. He defined the company's strategic vision, repositioned its core business, streamlined operations, and more than doubled its sales and profits. During this period, the company twice won the REX Award as the best custom brand marketer. Zeher began his career with Johnson & Johnson in 1972, where he progressed through various positions in sales and marketing management, and was appointed director of sales for the Marion Merrell Dow Consumer Products Company in 1989. Zeher returned to Johnson & Johnson as vice president of sales for the Personal Care Division in 1991 and later became vice president business development for J&J's Consumer Products Sector. Over the last 33 years, Zeher has served on the boards of various trade associations, and was recently elected (2010) to the board of directors of the Council for Responsible Nutrition (CRN); he is currently on the board of Matrixx Initiatives, Inc., in addition to his seat on the Nutrition 21 board.

46

Scott M. Melville

President and CEO CHPA Education: Born: Spouse: B.A., Bucknell University J.D., George Mason University School of Law July 16 Paige

Melville is the president and chief executive officer of CHPA. He joined the association in November 2010, and leads the organization's efforts to promote consumer empowerment of healthcare through science, advocacy, and education. With over 25 years of pharmaceutical industry and Capitol Hill experience, Melville has advocated on public policy issues before Congress, the U.S. Food and Drug Administration, and state legislative and regulatory bodies. Prior to joining CHPA, Melville served as senior vice president for government affairs and general counsel for the Healthcare Distribution Management Association (HDMA), the national association representing pharmaceutical wholesale distributors, where he was responsible for federal and state legislative, regulatory, legal, and political affairs. Melville joined HDMA in 2004. Before joining HDMA, Melville served as an attorney and head of government relations for Cephalon, Inc., an international biopharmaceutical company, and previously served in public policy and government affairs positions at Hoffmann-La Roche and Sterling Winthrop, Inc. He is a former chairman of the Pennsylvania Biotechnology Association. Prior to joining the healthcare industry, Melville served as legislative counsel and Appropriations Committee associate on the staff of U.S. Congressman Jerry Lewis. Melville is an alumnus of Bucknell University and the George Mason University School of Law. He is a member of the Virginia and Pennsylvania bars, the U.S. Chamber of Commerce Association Committee of 100, and a board member of the World SelfMedication Industry.

49

Roman G. Blazauskas

Vice President, Finance & Operations and Treasurer CHPA Education: Born: Spouse: B.A., The Catholic University of America March 25 Shawn Flaherty

Bill Head

Vice President, Government Affairs CHPA Education: Born: B.A., Government and Policy, University of Maryland M.A., Political Science, University of Nebraska J.D., University of Nebraska College of Law February 28

Blazauskas is in charge of CHPA's Finance department and also oversees all administrative and operations functions at the association. Blazauskas has a long history of association experience. He came to CHPA in 1998 from the Association of Fundraising Professionals where he served as director of finance and administration, overseeing the finance, human resources, and operations departments. Prior to that, he spent nearly eight years at the Travel Industry Association of America, moving through the ranks from senior accountant to controller, and finally, director of finance. Blazauskas also served in various accounting capacities at Computer Sciences Corporation, and before that at the Electronic Industries Association. Blazauskas is a Certified Public Accountant (CPA). He is a member of the American Institute of Certified Public Accountants, Virginia Society of Certified Public Accountants, and the American Society of Association Executives.

Head is responsible for the association's state and federal government affairs departments, and CHPA's political action committee (PAC). Prior to joining CHPA in January 2011, Head served as the senior vice president of government affairs for the Generic Pharmaceutical Association (GPhA) where he managed its federal lobbying strategy, represented GPhA before Congress, and managed the association's PAC program. Head has an extensive background in the healthcare industry, having managed numerous federal legislative issues and initiatives for Medco Health Solutions, the National Alliance of Health Information Technology, Blue Cross and Blue Shield Association, WellPoint Health Networks, and Mutual of Omaha. Before joining the private sector, he worked for then-Governor Ben Nelson of Nebraska as a senior policy advisor. Prior to that, he served overseas in the United States Navy.

50

51

Barbara A. Kochanowski, Ph.D.

Vice President, Regulatory Affairs CHPA Education: Born: Spouse: B.S., Pennsylvania State University M.S. and Ph.D., Nutritional Sciences, University of Illinois August 29 Dr. Ken Poirier

Theodore L. Peterson

Vice President, Corporate Development CHPA Education: Born: Spouse: B.A., Michigan State University January 6 Louise

Kochanowski is responsible for regulatory affairs activities, including cooperative programs with the U.S. Food and Drug Administration, ingredient safety, and dietary supplement programs at CHPA. Prior to joining CHPA in 2009, Kochanowski worked for more than 23 years in R&D at The Procter & Gamble Company (P&G), retiring in December 2008 as director, Global Personal Health Care, Oral Care, and Feminine Care Product Safety and Regulatory Affairs and Corporate Microbiology. She is experienced in pharmaceutical, medical device, and dietary supplement regulatory affairs, Rx-to-OTC switch, product safety, clinical research, and pharmacovigilance. While at P&G, Kochanowski was very active in CHPA activities, serving as chair of the Scientific Affairs Committee from 2007-2009, which brought with it an ex officio position on the CHPA Board of Directors for the same period. Kochanowski is a member of the American Society of Nutrition. She also serves on the board of directors of the American Foundation for Pharmaceutical Education.

Peterson is primarily focused on growing and retaining CHPA membership as well as helping to create business opportunities for the association's member companies. While Peterson officially joined CHPA's staff in 2003, he had been working with the association since 2001 on membership development and retention issues. As the senior corporate development officer, he is charged with ensuring that association programs are consistent with member needs and that there continues to be an introduction of new ideas to create opportunities for Active and Associate member companies. Peterson's career has been spent in the consumer products industry holding positions of increasing responsibility in sales, customer support, and development with such companies as Eastman Kodak Company, Whitehall-Robins Healthcare division of American Home Products Corporation (now Wyeth), the National Association of Chain Drug Stores, and Exel Logistics, before founding his own company, Ted Peterson Group LLC.

52

53

Heinz Schneider, Dr. med.

Vice President, Science & Medical Affairs CHPA Education: Born: Spouse: Dip. Reg. Affairs, University of Cardiff (UK) Dr. med. (M.D. equivalent), University of Vienna (Austria) December 22 Rosalia Rutter, Dr.Rer.Nat.

Emily Skor

Vice President, Communications & Alliance Development CHPA Education: Born: Spouse: B.A., Wellesley College January 27 Sean Cairncross

Schneider is the head of science and medical affairs within CHPA's Regulatory and Scientific Affairs department. He brings with him vast pharmaceutical experience in the areas of regulatory affairs, clinical research, and pharmacovigilance. Prior to joining CHPA as vice president, Regulatory & Scientific Affairs, in 2006, Schneider spent over 15 years working for pharmaceutical companies in Europe. He served as the regulatory affairs and clinical research manager at Dr. Kolassa + Merz in Vienna, Austria; head of regulatory affairs at Roche, Austria; head of international regulatory affairs and clinical research at Roche Consumer Health in Basel, Switzerland; and head of international regulatory affairs at Boots Healthcare International/BHI in Nottingham, UK; and, following the acquisition of BHI by Reckitt Benckiser/RB, he was global director regulatory, safety, and environment, RB Healthcare in the UK. Schneider was named to his current position in January of 2009. Schneider is a member of the American College of Preventive Medicine and Mitteleuropäische Gesellschaft für Regulatory Affairs. He also served as a member of the Regulatory Affairs Committee for the Association of the European Self-Medication Industry.

Skor leads the association's Communications department, and oversees and provides strategic direction for all association communications, media relations, public education, brand management, consumer and market research, and partnerships. She also oversees the CHPA Educational Foundation. Before joining CHPA in February 2011, Skor served as senior vice president, Dezenhall Resources, a nationally recognized crisis communications and issues management firm. For over a decade at Dezenhall she counseled Fortune 500 companies and industry associations in the healthcare sector on brand and reputation management issues. She developed comprehensive public affairs and public relations campaigns that included media relations, corporate communications, issue advocacy, constituent relations, coalition building, and consumer education. Prior to working at Dezenhall Resources, Skor worked at Cohn & Wolfe, a public affairs consultancy, and the Center for Defense Information, a nonprofit think tank. Skor serves on the board of directors for the National Council on Patient Information and Education, a coalition of over 125 organizations whose mission is to stimulate and improve communication of information on appropriate medicine use to consumers and healthcare professionals.

54

55

David C. Spangler, Esq.

CHPA Chairs

Senior Vice President, Policy, and General Counsel & Secretary CHPA Education: Center Born: A.B., Miami University (Ohio) J.D., George Washington University National Law December 13

CHPA Chairs

Spangler directs CHPA's legal affairs and international affairs, and oversees association policy initiatives. He has particular expertise in regulatory matters. Spangler joined CHPA in 1984 as a legislative analyst. He subsequently served in a number of roles for the association in the president's office; project management; international affairs; and, after completing law school in 1995, the association's legal department. Spangler was named a vice president in 1997, and a senior vice president in 2006. His responsibilities were expanded to include the legal function in 2011. Spangler serves on the board of directors of the World SelfMedication Industry. He is a member of the District of Columbia Bar as well as the American Society of Association Executives. He authored the chapter on OTC medicines in Modern Pharmaceutical Industry: A Primer (Jacobsen and Wertheimer, eds., 2009) and is on the editorial board for the Food and Drug Law Institute's Policy Forum. Spangler earned his Certificate in Organizational Management in 1991 from the U.S. Chamber of Commerce's Institute for Organization Management.

1881-1885 ... C.N. Crittenton 1885-1888 ... Fred H. Humphreys 1888-1894 ... R.V. Pierce 1894-1895 ... Alfred B. Scott 1895-1896 ... R.E. Queen 1896-1898 ... Thomas Doliber 1898-1901 ... V. Mott Pierce 1901-1902 ... E.C. DeWitt 1902-1903 ... H.B. Harding 1903-1904 ... D.S. Chamberlain 1904-1905 ... W.A. Talbot 1905-1915 ... Frank J. Cheney 1915-1916 ... A.H. Beardsley 1916-1923 ... Frank A. Blair 1923-1924 ... V. Mott Pierce 1924-1937 ... Frank A. Blair 1937-1939 ... George H. Miller 1939-1942 ... Charles S. Beardsley 1942-1944 ... Fred E. Rathburn 1944-1946 ... James Hill, Jr. 1946-1948 ... Kenneth A. Bonham 1948-1950 ... Walter R. Beardsley 1950-1952 ... Lupton Patten 1952-1954 ... E.T.T. Williams 1954-1956 ... Stanley I. Clark 1956-1958 ... Sherwood W. Silliman 1958-1960 ... Robert B. Brown 1960-1964 ... Joel Y. Lund 1964-1966 ... Ivan D. Combe 1966-1969 ... Hermon A. High 1969-1971 ... J.N. Cooke 1971-1973 ... William M. Bristol, III 1973-1975 ... DeWitt F. Helm, Jr. 1975 ............... O.G. Kennedy 1975-1977 ... Frank Markoe, Jr. 1977-1979 ... John T. McLoughlin 1979-1981 ... George E. Davy

1981-1983 ... Peter Godfrey 1983-1985 ... Charles A. Pergola 1985-1987 ... James H. Luther 1987-1989 ... William I. Bergman 1989-1991 ... William E. Learnard 1991-1992 ... Raymond P. LeFebvre 1992-1994 ... David E. Collins 1994-1995 ... Robert G. Donovan 1995-1996 ... Thomas M. Laughlin 1997-1999 ... Gary S. Balkema 1999-2001 ... Charles J. Hinkaty 2001-2002 ... Michael J. Valentino 2002-2004 ... Richard K. Green 2004-2006 ... Timothy G. Hayes 2006-2009 ... John T. Hendrickson 2009-2011 ...Christopher D. DeWolf 2011- ...............Paul L. Sturman

56

57

OTC medicines save Americans billions of dollars annually through fewer and unnecessary doctor visits, greater ability to treat an ailment faster, and less time lost away from work. 87% of physicians believe OTC medicines are an important part of overall healthcare. 93% of adults prefer to treat minor ailments with OTCs before seeking professional care. 85% of parents prefer to treat their kids' minor ailments with an OTC before seeking care. Doctors are more likely to recommend OTCs as a first response treatment for adult's minor ailments before a visit.

Yo u r H e a l t h A t H a n d . o r g

900 19th Street, NW, Suite 700, Washington, DC 20006 T 202.429.9260 F 202.223.6835 chpa-info.org

CP6/11-1K

Information

36 pages

Find more like this

Report File (DMCA)

Our content is added by our users. We aim to remove reported files within 1 working day. Please use this link to notify us:

Report this file as copyright or inappropriate

75900


You might also be interested in

BETA
Layout 2
Say on Pay in the 2011 Proxy Season
SAP_MyCRM.p65
Product Life Cycle Management in Manufacturing: Industry Business Issue Overview